Macrophage migration inhibitory factor in cardiovascular disease

Area of Science:

• Immunology
• Cardiovascular Medicine
• Molecular Biology

Background:

• Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine involved in inflammatory diseases.
• Emerging evidence implicates MIF in the pathogenesis of various cardiovascular diseases.

Purpose of the Study:

• To review the involvement of MIF in the inflammatory pathogenesis of atherosclerosis and its cardiovascular consequences.
• To explore the role of MIF in myocardial dysfunction, inflammation, and angiogenesis.
• To discuss MIF's potential as a therapeutic target and diagnostic marker for cardiovascular diseases.

Main Methods:

• Literature review synthesizing expression and functional studies on MIF in cardiovascular disease.
• Analysis of MIF's role in inflammatory processes like atherosclerosis, plaque formation, and arterial remodeling.
• Examination of MIF's signaling pathways, receptor interactions, and effects on cardiomyocytes and mononuclear cells.

Main Results:

• MIF plays a significant role in the inflammatory pathogenesis of atherosclerosis, unstable plaque formation, and post-injury arterial remodeling.
• MIF is implicated in aneurysm formation, myocardial infarction, ischemia-reperfusion injury, and other forms of myocardial dysfunction.
• Recent findings identify heptahelical receptors for MIF, elucidating its noncanonical ligand role and signal transduction in atherogenesis and inflammation.

Conclusions:

• MIF's unique functions distinguish it from other atherogenic cytokines, positioning it as a key therapeutic target.
• Targeting or exploiting MIF holds potential for therapeutic regression of atherosclerosis and improved management of cardiovascular diseases.
• MIF may serve as a valuable diagnostic marker in cardiovascular disease management.